Back to Treatments

Treatment

Ponatinib

1
Conditions
43
Trials
3,000
Participants
45%
Average Safety

Condition Evidence

Chronic myeloid leukemia

43 trials · 3,000 participants

93% effectiveness · 45% safety
Ponatinib | DFDA